WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsFresenius Medical Care Corporation (FMS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 646% more annual revenue ($19.43B vs $2.60B). AVAH leads profitability with a 10.6% profit margin vs 4.8%. AVAH trades at a lower P/E of 10.7x. AVAH earns a higher WallStSmart Score of 61/100 (C+).

AVAH

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.95

FMS

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHSignificantly Overvalued (-70.9%)

Margin of Safety

-70.9%

Fair Value

$4.67

Current Price

$12.41

$7.74 premium

UndervaluedFair: $4.67Overvalued
FMSUndervalued (+68.5%)

Margin of Safety

+68.5%

Fair Value

$76.29

Current Price

$22.69

$53.60 discount

UndervaluedFair: $76.29Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH3 strengths · Avg: 9.3/10
P/E RatioValuation
10.7x10/10

Attractively priced relative to earnings

Return on EquityProfitability
36.8%10/10

Every $100 of equity generates 37 in profit

EPS GrowthGrowth
38.5%8/10

Earnings expanding 38.5% YoY

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
12.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.748/10

Growing faster than its price suggests

Areas to Watch

AVAH3 concerns · Avg: 2.3/10
Price/BookValuation
9.4x4/10

Trading at 9.4x book value

Altman Z-ScoreHealth
0.952/10

Distress zone — elevated risk

Debt/EquityHealth
5.241/10

Elevated debt levels

FMS4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Profit MarginProfitability
4.8%3/10

4.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.74 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Price/Book, Altman Z-Score, Debt/Equity. Debt-to-equity of 5.24 is elevated, increasing financial risk.

Bear Case : FMS

The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

AVAH carries more volatility with a beta of 1.97 — expect wider price swings.

AVAH is growing revenue faster at 13.7% — sustainability is the question.

FMS generates stronger free cash flow (620M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AVAH scores higher overall (61/100 vs 58/100) and 13.7% revenue growth. FMS offers better value entry with a 68.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?